We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.57%
AUM
$2.29T
AUM Growth
+$147B
Cap. Flow
+$28.3B
Cap. Flow %
1.24%
Top 10 Hldgs %
14.11%
Holding
4,176
New
102
Increased
2,933
Reduced
915
Closed
113

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.56B
2
INVH icon
Invitation Homes
INVH
+$932M
3
MSFT icon
Microsoft
MSFT
+$818M
4
LUMN icon
Lumen
LUMN
+$746M
5
BDX icon
Becton Dickinson
BDX
+$706M

Sector Composition

Rank Sector Weight
1 Financials 15.99%
2 Technology 15.47%
3 Healthcare 12.33%
4 Industrials 10.79%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELDN icon
3951
Eledon Pharmaceuticals
ELDN
$261M
$168K ﹤0.01%
2,416
-88
-4% -$6.65K
PSTV icon
3952
Plus Therapeutics
PSTV
$26.6M
$166K ﹤0.01%
3
-1
-25% -$70.1K
FFBW
3953
DELISTED
FFBW, Inc. Common Stock
FFBW
$165K ﹤0.01%
+17,608
New +$168K
SA
3954
Seabridge Gold
SA
$2.78B
$164K ﹤0.01%
14,571
RGSE
3955
DELISTED
Real Goods Solar, Inc. Class A
RGSE
$162K ﹤0.01%
109,768
-13,547
-11% -$23K
ATXI
3956
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$161K ﹤0.01%
39
+17
+77% +$86.7K
DSS icon
3957
DSS Inc
DSS
$5.39M
$160K ﹤0.01%
160
-34
-18% -$19.4K
SVM
3958
Silvercorp Metals
SVM
$2.07B
$159K ﹤0.01%
60,974
XNET
3959
Xunlei
XNET
$340M
$158K ﹤0.01%
+10,215
New +$117K
ARGS
3960
DELISTED
Argos Therapeutics, Inc.
ARGS
$157K ﹤0.01%
52,269
+9,707
+23% +$32.6K
GEVO icon
3961
Gevo
GEVO
$360M
$156K ﹤0.01%
13,223
-20
-0.2% -$255
QBAK
3962
DELISTED
Qualstar Corp
QBAK
$155K ﹤0.01%
18,492
SLNG icon
3963
Stabilis Solutions
SLNG
$87.8M
$152K ﹤0.01%
12,636
-3,035
-19% -$37.7K
SOS
3964
SOS Limited
SOS
$16.6M
$152K ﹤0.01%
+4
New +$232K
SIEB icon
3965
Siebert Financial
SIEB
$66.7M
$150K ﹤0.01%
+11,099
New +$72.3K
SINT icon
3966
SiNtx Technologies
SINT
$10.8M
0
OBCI
3967
DELISTED
Ocean Bio-Chem Inc
OBCI
$145K ﹤0.01%
33,308
+6,497
+24% +$29.4K
CIX icon
3968
Comp X International
CIX
$349M
$144K ﹤0.01%
10,853
+66
+0.6% +$925
OXBR icon
3969
Oxbridge Re Holdings
OXBR
$10.6M
$144K ﹤0.01%
67,076
+3,892
+6% +$11.5K
LOV
3970
DELISTED
Spark Networks SE American Depositary Shares
LOV
$143K ﹤0.01%
11,270
-487,607
-98% -$3.29M
RDNW
3971
RideNow Group
RDNW
$238M
$142K ﹤0.01%
+1,378
New +$142K
IOR
3972
Income Opportunity Realty Investors
IOR
$141K ﹤0.01%
12,550
CTEK
3973
DELISTED
CynergisTek, Inc.
CTEK
$141K ﹤0.01%
34,796
+19,707
+131% +$70K
MGYR icon
3974
Magyar Bancorp
MGYR
$124M
$139K ﹤0.01%
13,139
+483
+4% +$4.92K
ORKA
3975
Oruka Therapeutics
ORKA
$5.82B
$138K ﹤0.01%
465
-48
-9% -$13.9K

Similar funds

Vanguard Group's Q4 2017 Portfolio in Review

As of Q4 2017, Vanguard Group held 4,176 positions worth $2.29T, up 6.9% from $2.14T the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Vanguard Group's Q4 2017 filing shows 102 new, 2,933 increased, 915 reduced and 113 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 7,351,313 shares worth $386M. The largest sale was CR Bard Inc., an estimated $2.53B.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Vanguard Group's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 7,351,313 shares worth $386M.
  • Vanguard Group added most to Alibaba in Q4 2017, an estimated $1.56B increase.
  • Vanguard Group's biggest Q4 2017 reduction was Lam Research, cutting an estimated $452M.
  • Vanguard Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $2.53B.
  • Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q4 2017.
  • Vanguard Group opened 102 new positions and closed 113 in Q4 2017.
  • Vanguard Group's portfolio value rose 6.9% quarter-over-quarter to $2.29T.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.